Abstract:Khadiga SM Salama, 1 Eman M Moazen, 1 Sawsan B Elsawy, 1 Sanaa F Kotb, 1 Eid M Mohammed, 2 Sara A Tahoun, 3 Marwa A A Ramadan, 3 Samar M Abd Elhamid, 3 Rania H M Bahi, 4 Etemad A Mohammad 5 1 Chest Diseases Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt; 2 Chest Diseases Department Faculty of Medicine for Men's, Al-Azhar University, Cairo, Egypt; 3 Clinical Pathology Department Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt; 4 Chest Diseases Department Faculty of Medicine, Zagazig University, Zagazig, Egypt; 5 Chest Diseases Department Faculty of Medicine, Benha University, Benha, Egypt Correspondence: Sawsan B Elsawy, Chest Diseases Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt, Email Background and Aim: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) has profound effects on disease progression and patients' quality of life. Emerging evidence suggests an association between alterations in the respiratory microbiome flora species and airway inflammation in patients with AECOPD. The present study aimed to describe the inflammatory cells and bacterial microbiome distributions in respiratory tract in Egyptian patients with AECOPD. Subjects and Methods: The present cross-sectional study included 208 patients with AECOPD. Sputum and broncho-alveolar lavage samples from the studied patients were submitted to microbial cultures using appropriate media. Total and differential leukocytic counts and were done via automated cell counter. Results: The present study included 208 AECOPD patients. They comprised 167 males (80.3%) and 41 females (19.7%) with an age of 57.9 ± 4.9 years. AECOPD was categorized as mild, moderate and severe in 30.8%, 43.3% and 26%, respectively. Sputum samples had significantly higher TLC, neutrophil percent and eosinophil percent when compared with BAL samples. In contrast, lymphocyte percent was significantly higher in BAL samples. Sputum specimens had significantly lower frequency of positive growths (70.2% versus 86.5%, p = 0.001). Among the identified organisms, sputum specimens had significantly lower frequency of Strept. pneumoniae (14.4% versus 30.3%, p = 0.001), Klebsiella pneumoniae (19.7% versus 31.7%, p = 0.024), Haemophilus influenzae (12.5% versus 26.9%, p = 0.011), Pseudomonas aeruginosa (2.9% versus 10%, p = 0.019) and Acinetobacter spp . (1.9% versus 7.2%, p = 0.012) growths when compared with BAL samples. Conclusion: The present study could identify a distinctive pattern of inflammatory cell distribution in sputum and BAL samples of AECOPD patients. The most commonly isolated organisms were Klebsiella pneumoniae and Strept. pneumoniae . Keywords: chronic obstructive pulmonary disease, COPD exacerbation, inflammatory cells, bacterial microbiome, sputum culture, bronchoalveolar culture Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity. It is one of the top three causes of death worldwide and 90% of these deaths occur in low- and middle-income countries. 1,2 Airways of almost 50% of stable COPD patients are colonized by potentially pathogenic microorganisms (PPMs). The most commonly isolated microbes are H. influenzae, M. catarrhalis, S. pneumoniae, S. aureus, and P. aeruginosa . 3 Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is an acute and sustained worsening of a patient's condition from a stable state. 4 Possible risk factors include air pollution, seasonal change, ethnic background, associated comorbidities, poor exercise capacity and obesity. 5 Management strategy usually includes bronchodilators and corticosteroids as first-line treatments. In patients with severe exacerbations, noninvasive ventilation, magnesium, ketamine, and epinephrine may be considered. Mechanical ventilation may be needed in selected situations. 6 AECOPD has profound effects on disease progression and patients' quality of life. Prevention of early recurrence and identification of causative agents remains one of the top unmet needs in management of AECOPD. 7 Remarkably, newly developed vaccines against the most frequent bacteria identified in AECOPD are assessed by undergoing trials. 8 Emerging evidence suggests an association between alterations in the respiratory microbial flora species and airway inflammation in patients with AECOPD. 9 Identification of respiratory microbiome has been increasingly recognized as a cornerstone in a modern management direction of AEC -Abstract Truncated-

Dection and Analysis of Pathogens in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Detection of relationship between pathogens of acute exacerbation of chronic obstructive pulmonary disease and comprehensive evaluation classification

Pathogens in Patients with Chronic Obstructive Pulmonary Disease at Acute Exacerbation

Analysis of bacterial pathogens isolated from lower respiratory tract in patients with acute exacerbation of chronic obstructive pulmonary diseases

Bacteriology in Acute Exacerbation in Patients Hospitalized Frequently for Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Identification of priority pathogens for aetiological diagnosis in adults with community-acquired pneumonia in China: a multicentre prospective study

Spectrum and Antimicrobial Resistance of Common Pathogenic Bacteria Isolated from Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Mainland of China.

Correlation Between Sputum Culture Results and Serum Levels of C-reactive Protein, Amyloid A and Procalcitonin in Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Analysis of Viral Infection and Biomarkers in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Bacterial Infection, Airway and Systemic Inflammation and Clinical Outcomes Before and after Treatment of AECOPD, a Longitudinal and Cross-Sectional Study.

Atypical Pathogen Distribution in Chinese Hospitalized AECOPD Patients: A Multicenter Cross-Sectional Study

Sputum antibiogram in acute exacerbation of chronic obstructive pulmonary disease

Characteristics of Pathogens Causing Ventilator-Associated Pneumonia in Patients with Chronic Obstructive Pulmonary Diseases During Acute Exacerbation Period

Bacterial Species and Inflammatory Cell Variability in Respiratory Tracts of Patients with Chronic Obstructive Pulmonary Disease Exacerbation: A Multicentric Study

Determination of Biomarkers in Exhaled Breath Condensation of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Clinical Implications

The Sputum Microbiome Associated with Different Sub-Types of AECOPD in a Chinese Cohort

Comprehensive analysis of the gut microbiota in patients with chronic obstructive pulmonary disease of varying severity-A prospective, observational study

Distribution and drug resistance of pathogens from lower respiratory tract of patients with acute exacerbated chronic obstructive pulmonary diseases in respiratory intensive care unit

Distribution and Antibiotic Resistance of Isolates from Lower Respiratory Tract in Mechanically Ventilated Patients with COPD

Investigation on the Pathological Mechanism of Frequent Exacerbators With Chronic Obstructive Pulmonary Disease Based on the Characteristics of Respiratory Flora

Microbiome-host interactions in the pathogenesis of acute exacerbation of chronic obstructive pulmonary disease